188 related articles for article (PubMed ID: 34657908)
1. Central Nervous System-related Graft-versus-host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.
Kaito Y; Yui S; Inai K; Onai D; Kinoshita R; Yamanaka S; Okamoto M; Wada R; Ohashi R; Inokuchi K; Yamaguchi H
Intern Med; 2021; 60(20):3299-3304. PubMed ID: 34657908
[TBL] [Abstract][Full Text] [Related]
2. Case report: Central nervous system involvement of human graft versus host disease: Report of 7 cases and a review of literature.
Ruggiu M; Cuccuini W; Mokhtari K; Meignin V; Peffault de Latour R; Robin M; Fontbrune FS; Xhaard A; Socié G; Michonneau D
Medicine (Baltimore); 2017 Oct; 96(42):e8303. PubMed ID: 29049232
[TBL] [Abstract][Full Text] [Related]
3. A case of central nervous system graft-versus-host disease following allogeneic stem cell transplantation.
Min GJ; Park S; Park SS; Yoon JH; Lee SE; Cho BS; Eom KS; Lee S; Kim HJ; Min CK; Cho SG; Kim DW; Lee JW; Kim YJ
Int J Hematol; 2019 Nov; 110(5):635-639. PubMed ID: 31309419
[TBL] [Abstract][Full Text] [Related]
4. Graft-Versus-Host-Disease of the Central Nervous System and Lung in a Patient With Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report.
Li Z; Wen X; Geng Y; Wu T
J Pediatr Hematol Oncol; 2021 Nov; 43(8):e1088-e1092. PubMed ID: 33480650
[TBL] [Abstract][Full Text] [Related]
5. Acute Graft-
Vinnakota JM; Zeiser R
Front Immunol; 2021; 12():748019. PubMed ID: 34691059
[TBL] [Abstract][Full Text] [Related]
6. The black swan: a case of central nervous system graft-versus-host disease.
Butera S; Tavarozzi R; Brunello L; Rivela P; Sofia A; Viero L; Salvio M; Ladetto M; Zallio F
J Basic Clin Physiol Pharmacol; 2023 Nov; 34(6):805-809. PubMed ID: 37843253
[TBL] [Abstract][Full Text] [Related]
7. Ex Vivo CD34
Barba P; Hilden P; Devlin SM; Maloy M; Dierov D; Nieves J; Garrett MD; Sogani J; Cho C; Barker JN; Kernan NA; Castro-Malaspina H; Jakubowski AA; Koehne G; Papadopoulos EB; Prockop S; Sauter C; Tamari R; van den Brink MR; Avecilla ST; Meagher R; O'Reilly RJ; Goldberg JD; Young JW; Giralt S; Perales MA; Ponce DM
Biol Blood Marrow Transplant; 2017 Mar; 23(3):452-458. PubMed ID: 28017734
[TBL] [Abstract][Full Text] [Related]
8. Central and peripheral nervous system immune mediated demyelinating disease after allogeneic hemopoietic stem cell transplantation for hematologic disease.
Delios AM; Rosenblum M; Jakubowski AA; DeAngelis LM
J Neurooncol; 2012 Nov; 110(2):251-6. PubMed ID: 22915190
[TBL] [Abstract][Full Text] [Related]
9. Risk factors and survival analysis for central nervous system complications after allogeneic hematopoietic stem cell transplantation.
Chen X; Peng M; Fu B; Chen Y; Hua J; Zeng C; Xu Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Oct; 45(10):1176-1184. PubMed ID: 33268578
[TBL] [Abstract][Full Text] [Related]
10. [Liver biopsy in the management of liver dysfunction after allogeneic hematopoietic stem-cell transplantation].
Chen H; Huang XJ; Liu KY; Xu LP; Wang H; Liu DH; Lu J; Lu DP
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(43):3062-6. PubMed ID: 16324408
[TBL] [Abstract][Full Text] [Related]
11. Central nervous system graft-versus-host disease (CNS-GvHD) after allogeneic haematopoietic stem cell transplantation.
Polchlopek Blasiak K; Simonetta F; Vargas MI; Chalandon Y
BMJ Case Rep; 2018 Jan; 2018():. PubMed ID: 29330269
[TBL] [Abstract][Full Text] [Related]
12. Decitabine induction with myeloablative conditioning and allogeneic hematopoietic stem cell transplantation in high-risk patients with myeloid malignancies is associated with a high rate of infectious complications.
D'Angelo CR; Hall A; Woo KM; Kim K; Longo W; Hematti P; Callander N; Kenkre VP; Mattison R; Juckett M
Leuk Res; 2020 Sep; 96():106419. PubMed ID: 32683127
[TBL] [Abstract][Full Text] [Related]
13. Noninfectious Neurologic Complications after Allogeneic Hematopoietic Stem Cell Transplantation.
Balaguer-Rosello A; Bataller L; Piñana JL; Montoro J; Lorenzo I; Villalba A; Freiria C; Santiago M; Sevilla T; Muelas N; Guerreiro M; Carretero C; Gómez I; Solves P; Sanz MÁ; Sanz G; Sanz J
Biol Blood Marrow Transplant; 2019 Sep; 25(9):1818-1824. PubMed ID: 31132454
[TBL] [Abstract][Full Text] [Related]
14. [Central nervous system involvement of graft versus host disease after allogeneic hematopoietic stem cell transplantation for adult T cell leukemia].
Ide T; Iida K; Katsuya H; Ito H; Aishima S; Hara H
Rinsho Shinkeigaku; 2022 Jan; 62(1):33-38. PubMed ID: 34924471
[TBL] [Abstract][Full Text] [Related]
15. A Case of Multiple Sclerosis-Like Relapsing Remitting Encephalomyelitis Following Allogeneic Hematopoietic Stem Cell Transplantation and a Review of the Published Literature.
Das J; Gill A; Lo C; Chan-Lam N; Price S; Wharton SB; Jessop H; Sharrack B; Snowden JA
Front Immunol; 2020; 11():668. PubMed ID: 32431694
[TBL] [Abstract][Full Text] [Related]
16. Positive impact of chronic graft-versus-host disease on the outcome of patients with de novo myelodysplastic syndrome after allogeneic hematopoietic cell transplantation: a single-center analysis of 115 patients.
Hiramoto N; Kurosawa S; Tajima K; Okinaka K; Tada K; Kobayashi Y; Shinohara A; Inoue Y; Ueda R; Tanaka T; Kim SW; Yamashita T; Heike Y; Fukuda T
Eur J Haematol; 2014 Feb; 92(2):137-46. PubMed ID: 24127668
[TBL] [Abstract][Full Text] [Related]
17. Idiopathic inflammatory demyelinating diseases of the central nervous system in patients following allogeneic hematopoietic stem cell transplantation: a retrospective analysis of incidence, risk factors and survival.
Zhang XH; Huang XJ; Liu KY; Xu LP; Liu DH; Chen H; Han W; Chen YH; Wang FR; Wang JZ; Wang Y; Zhao T; Chen Y; Fu HX; Wang M
Chin Med J (Engl); 2013 Mar; 126(6):1096-102. PubMed ID: 23506585
[TBL] [Abstract][Full Text] [Related]
18. European Group for Blood and Marrow Transplantation score correlates with outcomes of older patients undergoing allogeneic hematopoietic stem cell transplantation.
Chien SH; Liu YC; Liu CJ; Ko PS; Wang HY; Hsiao LT; Lin JS; Chiou TJ; Liu CY; Gau JP
J Chin Med Assoc; 2020 Mar; 83(3):238-244. PubMed ID: 31904659
[TBL] [Abstract][Full Text] [Related]
19. Post-Transplant Cyclophosphamide Combined with Anti-Thymocyte Globulin as Graft-versus-Host Disease Prophylaxis for Allogeneic Hematopoietic Cell Transplantation in High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome.
Alanazi W; Chen S; Lipton JH; Kim DD; Viswabandya A; Kumar R; Lam W; Law AD; Al-Shaibani Z; Mattsson J; Michelis FV
Acta Haematol; 2021; 144(1):66-73. PubMed ID: 32428903
[TBL] [Abstract][Full Text] [Related]
20. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
